Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Same Dose, Different Response: Vitamin D and the MS Metabolome
Genetics
Same Dose, Different Response: Vitamin D and the MS Metabolome

06, Sep 2026

2
Same Dose, Different Response: Vitamin D and the MS Metabolome
Genetics
Four Groups of Thirty: NMR Metabolomics Across the MS Subtypes

05, Sep 2026

3
Two Cohorts, Three Classifiers: Metabolomic Signatures of MS Severity
Genetics
Two Cohorts, Three Classifiers: Metabolomic Signatures of MS Severity

04, Sep 2026

4
From Metabolite Signature to Drug Target: Glycolysis in Relapsing-Remitting MS
Genetics
From Metabolite Signature to Drug Target: Glycolysis in Relapsing-Remitting MS

03, Sep 2026

5
A Blood Test for Progressive MS? What the Metabolite Signature Actually Shows
Genetics
A Blood Test for Progressive MS? What the Metabolite Signature Actually Shows

02, Sep 2026

Categories:
Genetics
When Genetic Risk Meets Childhood Obesity: What UK Biobank Reveals About Gene–Environment Interactions in Multiple Sclerosis
Genetics
When Genetic Risk Meets Childhood Obesity: What UK Biobank Reveals About Gene–Environment Interactions in Multiple Sclerosis

21, Feb 2026

Rare Predicted Pathogenic Variants in GWAS-Implicated Genes Reveal a Distinct Genetic Architecture in Familial Multiple Sclerosis
Genetics
Rare Predicted Pathogenic Variants in GWAS-Implicated Genes Reveal a Distinct Genetic Architecture in Familial Multiple Sclerosis

21, Feb 2026

Decoding Multiple Sclerosis Susceptibility Through Cell-Resolved Epigenomics and 3D Genome Architecture
Genetics
Decoding Multiple Sclerosis Susceptibility Through Cell-Resolved Epigenomics and 3D Genome Architecture

23, Feb 2026

Cross-Ancestry Performance of a European-Derived Polygenic Risk Score for Multiple Sclerosis: Insights from a British South Asian Cohort
Genetics
Cross-Ancestry Performance of a European-Derived Polygenic Risk Score for Multiple Sclerosis: Insights from a British South Asian Cohort

24, Feb 2026